IOP Reduction in Pigmentary Glaucoma Using DSLT
Part of paid clinical trials in Houston, Texas.
- Sponsor
- Mann Eye Institute
- Study ID
- NCT07281391
- Status
- Recruiting
Conditions
- Pigmentary Dispersion Glaucoma
- Pigmentary Dispersion Syndrome
Eligibility Criteria
- Sex
- ALL
- Age
- N/A - N/A
- Healthy Volunteers
- Not accepted
Interventions
- Voyager DSLT — DEVICEDSLT is an innovative adaptation of traditional SLT. Rather than using a gonioscopic lens, DSLT applies laser energy directly through the limbus to the trabecular meshwork in a few seconds.
Study Details
This study is a single-site, single-arm, prospective, observational study of IOP reduction after DSLT. Subjects will be assessed up to 12 months post-operatively. Clinical evaluations will include IOP and number of glaucoma medications.
Key Dates
- Start date
- Mar 19, 2026
- Status verified
- Apr 2026
- Primary completion
- Apr 1, 2027
- Completion
- Apr 1, 2027
Study Design
- Enrollment
- 45 participants (estimated)
Primary Outcome Measure
Mean washed-out IOP change post-DSLT compared to washed-out baseline IOP [ Time Frame: 6 months post-DSLT ]
Central Contacts
- Melissa Wright713-580-2500
Locations (1)
| Facility | City | State | ZIP | Site coordinators |
|---|---|---|---|---|
| Mann Eye Institute | Houston | Texas | 76134-2099 | Alex Hacopian, MD (PRINCIPAL_INVESTIGATOR) |
Find similar trials in Houston, TX
By research site